While historical studies have demonstrated connections between the PI3K-AKT-mTOR pathway and metabolism, the model systems used have often relied on comparisons between cell lines that have multiple genetic differences or used over-expression strategies that are not reflective of patient tumour genetics. The gene discussed is MTOR; the disease is neoplasm.